Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Vaccine|January 4, 2006
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western KenyaJosé A Stoute, Joash Gombe, Mark R Withers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromesLanlan Shen, Hagop Kantarjian, Yi Guo, et al.
Vaccine|April 23, 2003
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative studyGeoffrey J Gorse, Theresa Z O'Connor, Stephen L Young, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
Breast Cancer Research and Treatment|June 15, 2006
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2012
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiativeApostolia-Maria Tsimberidou, Nancy G Iskander, David S Hong, et al.
Nature Medicine|August 2, 2008
Circulating mutant DNA to assess tumor dynamicsFrank Diehl, Kerstin Schmidt, Michael A Choti, et al.
JACC. Heart Failure|January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus PanelVanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
Clinical Trials (London, England)|April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challengesThomas R Fleming, David L DeMets, Matthew T Roe, et al.
The Journal of Rheumatology|April 4, 2006
Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extensionAndreas Reiff, Daniel J Lovell, Janet Van Adelsberg, et al.
Pageof 18